Rosetta Genomics Ltd. Accounts Receivable, Credit Loss Expense (Reversal)
Rosetta Genomics Ltd. reported Accounts Receivable, Credit Loss Expense (Reversal) of $1.07 million for the 12-month period ending 2016-12-31, per its 6-K filed 2017-10-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2017-10-10
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2016-12-31 | $1.07M 6-K · filed 2017-10-10 |
| 2015-12-31 | $0.00 6-K · filed 2017-10-10 |
| 2014-12-31 | $0.00 6-K · filed 2017-10-10 |